← Leaderboards
Sanjay Misra
Mayo Clinic Rochester
$12,663,075
Attributed
$13,571,016
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,571,016 · 5
By mechanism
R01$12,470,633 · 3
R44$997,033 · 1
R56$103,350 · 1
Top collaborators
- Rajiv Kumar4 shared
- Aaron Miller2 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Lilach O Lerman$25,904,470
- Sujit Basu$9,062,631
Others in their field
Top investigators on “Venous”
- David R. Weir · University Of Michigan At Ann Arbor$164,561,836
- Paul M. Ridker · Brigham And Women'S Hospital$57,875,056
- Paul S. Aisen · Cognition Therapeutics, Inc.$39,054,712
- Joel S. Bennett · University Of Pennsylvania$35,473,908
- Robert A Hummer · Univ Of North Carolina Chapel Hill$35,410,813
- Kenneth M Langa · University Of Michigan At Ann Arbor$34,192,762
Research focus
VenousHyperplasiaStenosisArteriovenous FistulaHemodialysisEnd Stage Renal FailureBlood VesselsRenal Replacement TherapyGene ExpressionCellsFamily SuidaeVeinsMacrophageAffectInflammatoryChronic Kidney FailureClinical TrialsTunica AdventitiaHistologicAngioplastyHypoxiaGenesIn VitroInflammation
Grant awards (24)
The role of hypoxia in venous neointimal hyperplasia in hemodialysis grafts$720,439
R01 · FY2025 · HL · contact PI
Monocyte chemoattractant Proteins and Vascular Injury$710,158
R01 · FY2025 · DK · contact PI
Development of a Treatment to Improve Arteriovenous Fistula Function$497,143
R44 · FY2025 · DK
The role of hypoxia in venous neointimal hyperplasia in hemodialysis grafts$755,207
R01 · FY2024 · HL · contact PI
Monocyte chemoattractant Proteins and Vascular Injury$681,751
R01 · FY2024 · DK · contact PI
Development of a Treatment to Improve Arteriovenous Fistula Function$499,890
R44 · FY2024 · DK
The role of hypoxia in venous neointimal hyperplasia in hemodialysis grafts$775,614
R01 · FY2023 · HL · contact PI
Monocyte chemoattractant Proteins and Vascular Injury$710,158
R01 · FY2023 · DK · contact PI
The role of hypoxia in venous neointimal hyperplasia in hemodialysis grafts$783,583
R01 · FY2022 · HL · contact PI
The role of hypoxia in venous neointimal hyperplasia in hemodialysis grafts$780,568
R01 · FY2021 · HL · contact PI
The role of hypoxia in venous neointimal hyperplasia in hemodialysis grafts$789,804
R01 · FY2020 · HL · contact PI
Regulatory gene-chemokine networks in the formation of hemodialysis AVF stenosis$103,350
R56 · FY2020 · DK · contact PI
The Role of Hypoxia In Venous Neointimal Hyperplasia In Hemodialysis Grafts$573,802
R01 · FY2019 · HL · contact PI
Regulatory gene-chemokine networks in the formation of hemodialysis AVF stenosis$238,500
R01 · FY2019 · DK · contact PI
The Role of Hypoxia In Venous Neointimal Hyperplasia In Hemodialysis Grafts$573,802
R01 · FY2018 · HL · contact PI
Regulatory gene-chemokine networks in the formation of hemodialysis AVF stenosis$238,500
R01 · FY2018 · DK · contact PI
The Role of Hypoxia In Venous Neointimal Hyperplasia In Hemodialysis Grafts$573,821
R01 · FY2017 · HL · contact PI
Regulatory gene-chemokine networks in the formation of hemodialysis AVF stenosis$238,500
R01 · FY2017 · DK · contact PI
The Role of Hypoxia In Venous Neointimal Hyperplasia In Hemodialysis Grafts$573,714
R01 · FY2016 · HL · contact PI
The Role of Hypoxia In Venous Neointimal Hyperplasia In Hemodialysis Grafts$538,646
R01 · FY2014 · HL · contact PI
The Role of Hypoxia In Venous Neointimal Hyperplasia In Hemodialysis Grafts$527,019
R01 · FY2013 · HL · contact PI
The role of hypoxia in venous neointimal hyperplasia in hemodialysis grafts$557,660
R01 · FY2012 · HL · contact PI
The role of hypoxia in venous neointimal hyperplasia in hemodialysis grafts$561,855
R01 · FY2011 · HL · contact PI
The role of hypoxia in venous neointimal hyperplasia in hemodialysis grafts$567,532
R01 · FY2010 · HL · contact PI